Corticosteroids for viral myocarditis

Cochrane Database of Systematic Reviews

Volumn 2013, Issue 10, 2013, Pages

  Chen, Huai Sheng ^a   Wang, Wei ^a   Wu, Sheng Nan ^a   Liu, Jian Ping ^b  

^a SHENZHEN PEOPLE'S HOSPITAL   (China)

^b BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXYBUTYRATE DEHYDROGENASE; ANTIVIRUS AGENT; CORTICOSTEROID; CREATINE KINASE; CREATINE KINASE MB; HEART ENZYME; PLACEBO; AZATHIOPRINE; CYCLOSPORIN; PREDNISONE;

CAUSE OF DEATH; CHILD DEATH; CLINICAL EFFECTIVENESS; CREATINE KINASE BLOOD LEVEL; DRUG EFFICACY; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART TRANSPLANTATION; HUMAN; META ANALYSIS; MORTALITY; NEW YORK HEART ASSOCIATION CLASS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; VIRUS MYOCARDITIS; ACUTE DISEASE; ADULT; CHILD; CHRONIC DISEASE; ENZYMOLOGY; MYOCARDITIS; VIROLOGY; VIRUS DISEASES;

ACUTE DISEASE; ADRENAL CORTEX HORMONES; ADULT; AZATHIOPRINE; CHILD; CHRONIC DISEASE; CYCLOSPORINE; HUMANS; MYOCARDITIS; PREDNISONE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; VIRUS DISEASES;

EID: 84925558751     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD004471.pub3     Document Type: Review

References (79)

1. Aziz KU, Patel N, Sadullah T, Tasneem H, Thawerani H, Talpur S. Acute viral myocarditis: role of immunosuppression: a prospective randomised study. Cardiology in the Young 2010;20(5):509-15.
2. Latham RD, Mulrow JP, Virmani R, Robinowitz M, Moody JM. Recently diagnosed idiopathic dilated cardiomyopathy: incidence of myocarditis and efficacy of prednisone therapy. American Heart Journal 1989;117(4):876-882.
3. Liao RH, Li L, Wang X. Therapeutic effects of comprehensive program plus hormone on viral myocarditis. Acta Academiae Medicinae Militaris Tertiae (Chinese) 2005;27(6):575-6.
4. Ma PaiRan, Wang ShuJun, Zhuang JianXin, Huang Lei. The treatment effect of corticosteroids on reducing myocardial enzyme in viral myocarditis in children. Shan Dong Medical Journal 2001;41(19):13-14.
5. Maisch B, Herzum M, Hufnagel G, Hengstenberg C, Schonian U, Bittinger A, et al.Immunosuppressive treatment in auto-reactive myocarditis results from a placebo-controlled trial. Journal of the American College of Cardiology 1993;21(2 Suppl A):21A.
6. Maisch B, Herzum M, Hufnagel G, Hengstenberg C, Schonian U, Bittinger A, et al.Immunosuppressive treatment in auto-reactive myocarditis: results from a placebo-controlled trial. Journal of the American College of Cardiology 1995;Special Issue:325A.
7. Maisch B, Schonian U, Hengstenberg C, Herzum M, Hufnagel G, Bethge C, et al.Immunosuppressive treatment in autoreactive myocarditis--results from a controlled trial. Postgraduate Medical Journal 1994;70(Suppl 1):S29-34.
8. Hahn EA, Hartz VL, Moon TE, O'Connell JB, Herskowitz A, Mcmanus BM, et al.The myocarditis treatment trial: design, methods and patient enrolment. European Heart Journal 1995;16(Suppl):162-7.
9. Mason JW, O'Connell JB, Herskowitz A, Rose NR, McManus BM, Billingham ME, et al.A clinical trial of immunosuppressive therapy for myocarditis: The Myocarditis Treatment Trial Investigators. New England Jounral of Medicine 1995;333(5):269-75.
10. Wojnicz R, Nowalany-Kozielska E, Szczurek-Katanski K, Wodniecki J, Nozynski J, Zembala M, et al.Randomized studies of new therapeutic management in patients with myocarditis. Journal of the American College of Cardiology 1999;2(Suppl A):506A.
11. Wojnicz R, Nowalany-Kozielska E, Wojciechowska C, Glanowska G, Wilczewski P, Niklewski T, et al.Randomized, placebo-controlled study for immunosuppressive treatment of inflammatory dilated cardiomyopathy: two-year follow-up results. Circulation 2001;104(1):39-45. [PUBMED: 11435335]
12. Yang CQ, Ding DP. Treatment effects of Shenmai injection combined corticosteroids on acute viral myocarditis in children. Lishizhen Medicine and Materia Medica Research 2006;17(5):872-3.
13. Camargo PR, Snitcowsky R, Da Luz PL, Mazzieri R, Higuchi ML, Rati M, et al.Favorable effects of immunosuppressive therapy in children with dilated cardiomyopathy and active myocarditis. Pediatric Cardiology 1995;16(2):61-8.
14. Chen SX, Chang BL, Bao SH. Integrated traditional and Western medicine treatment of severe viral myocarditis. Zhongguo Zhong Xi Yi Jie He Za Zhi 1992;12(7):398-401.
15. Hufnagel G, Pankuweit S, Richter A, Schonian U, Maisch B. The European Study of Epidemiology and Treatment of Cardiac Inflammatory Diseases (ESETCID). First epidemiological results. Herz 2000;25(3):279-285.
16. Maisch B, Hufnagel G, Schonian U, Hengstenberg C. The European Study of Epidemiology and Treatment of Cardiac Inflammatory Disease (ESETCID). European Heart Journal 1995;16(Suppl O):173-5.
17. Frustaci A, Russo MA, Chimenti C. Randomized study on the efficacy of immunosuppressive therapy in patients with virus-negative inflammatory cardiomyopathy: the TIMIC study. European Heart Journal 2009;30(16):1995-2002.
18. Kong Qing-fu, Song Shu-zhi, Xie Xue-ying, Zhang Xin-hua, Yue Ge-jie, Chen Zhao-li. Clinical study on therapeutic effects of treatment according to syndrome differentiation of Traditional Chinese Medicine combined with captopril on severe viral myocarditis complicated heart failure. Zhongguo Zhong Xi Yi Jie He Za Zhi 2001;21(7):513-5.
19. Li SenLin, Zhang ZhiGan, Zhou PengYu. Effect of synthetic action of HuangQi, cortisone on acute viral myocarditis. ZhongGuo Zhong Xi Yi Jie He Za Zhi 1997;17(2):118-9.
20. Ma PaiRan, Wang ShuJun, Yang XiaoHui, Ouyan ShiXiang. The differentia and value of anticardiolipin antibody between pre- and pro- treatment of corticosteroids in children with viral myocarditis. Shandong Medical Journal 2002;42(23):1-3.
21. Mao KeJiang, Li YiNan. Application research on staged immunological intervention in viral myocarditis patients. Modern Hospital 2007;7(6):31-3.
22. Sun Dabao. Corticosteroids treatment effects in 36 cases diagnosed with viral myocarditis with ventricle premature beats. Journal of Zhenjiang Medical College 1999;9(2):211.
23. Wu Yao-zhang, Chen Bing-Wang. Observation on curative effects of astragalus injection combined with glucocorticoid on acutely severe viral myocarditis. Zhongguo Zhong Xi Yi Jie He Ji Jiu Za Zhi 1999;6(8):350-2.
24. Zhang ChunTang, Li AnMin, Li Na. Effect of calcium dibutyryladenosine cyclophosph-ate on viral myocarditis. Central Plains Medical Journal 2006;33(8):80-81.
25. Zhang JinFu. Effects of 1, 6-FDP combined HuangQi injection on 30 children with viral myocardiits. China Eugenic Genetics Medicine 2008;16(6):131-2.
26. Adedayo O, Iheonunekwu N, Jefferson D. Acute fulminant myocarditis and the 2009 pandemic influenza A virus (H1N1). West Indian Medical Journal 2011;60(2):217-9.
27. Andreoletti L, Leveque N, Boulagnon C, Brasselet C, Fornes P. Viral causes of human myocarditis. Archives of Cardiovascular Disease 2009;102(6-7):559-68.
28. Angelini A, Calzolari V, Calabrese F, Boffa GM, Maddalena F, Chioin R, et al.Myocarditis mimicking acute myocardial infarction: role of endomyocardial biopsy in the differential diagnosis. Heart 2000;84(3):245-50.
29. Barbaro G, Barbarini G. Human immunodeficiency virus and cardiovascular risk. Indian Journal of Medical Research 2011;134(6):898-903.
30. Batra AS, Lewis AB. Acute myocarditis. Currence Opinion in Pediatrics 2001;13(3):234-9.
31. Baughman KL. Diagnosis of myocarditis-death of Dallas Criteria. Circulation 2006;113(4):593-5.
32. Cabral M, Brito MJ, Conde M, Oliveira M, Ferreira G. Fulminant myocarditis associated with pandemic H1N1 influenza A virus. Revista Portuguesa de Cardiologia [Portuguese Journal of Cardiology] 2012;31(7-8):517-20.
33. Calderaro D, Dos Santos Sde S, Tonacio AC, Gualandro DM, Rezende PC, Yu PC, et al.Acute myocarditis in H1N1 influenza A virus infection. Revista Associação da Médica Brasiliera 2010;56(4):394.
34. Chan KY, Iwahara M, Benson LN, Wilson GJ, Freedom RM. Immunosuppressive therapy in the management of acute myocarditis in children: a clinical trial. Journal of the American College of Cardiology 1991;17(2):458-60.
35. Chen HS, Wen JM, Wu SN. Clinical management and relevant issues of viral myocarditis. Chinese Journal of Practical Internal Medicine 2008;28(6):510-2.
36. Cheng TO. Prevalence of viral myocarditis. Archives of Internal Medicine 2003;163(14):1742. [PUBMED: 12885693]
37. Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-34.
38. Fukae S, Ashizawa N, Morikawa S, Yano K. A fatal case of fulminant myocarditis with human herpes virus-6 infection. Internal Medicine 2000;39(8):632-6.
39. Gagliardi MG, Bevilacqua M, Bassano C, Leonardi B, Boldrini R, Camassei FD. Long term follow up of children with myocarditis treated by immunosuppression and of children with dilated cardiomyopathy. Heart 2004;90(10):1167-71.
40. Garg A, Shiau J, Guyatt G. The ineffectiveness of immunosuppressive therapy in lymphocytic myocarditis: an overview. Ann Intern Med 1998;129(4):317-22.
41. Gdynia G, Schnitzler P, Brunner E, Kandolf R, Blaker H, Daum E, et al.Sudden death of an immunocompetent young adult caused by novel (swine origin) influenza A/H1N1-associated myocarditis. Virchows Archiv 2011;458(3):371-6.
42. Haessler S, Paez A, Rothberg M, Higgins T. 2009 pandemic H1N1-associated myocarditis in a previously healthy adult. Clinical Microbiology and Infection 2011;17(4):572-4.
43. Hamilton TW, Goodman SM, Figgie M. SAS weekly rounds: avascular necrosis. HSS Journal 2009;5(2):99-113.
44. Heininger A, Haeberle HA, Fischer I, Beck R, Riessen R, Rohde F, et al.Cytomegalovirus reactivation and associated outcome of critically ill patients with severe sepsis. Critical Care 2011;15(2):R77.
45. Hia CP, Yip WC, Tai BC, Quek SC. Immunosuppressive therapy in acute myocarditis: an 18 year systematic review. Archives of Disease in Childhood 2004;89(6):580-4. [PUBMED: 15155409]
46. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-60.
47. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org. Wiley -Blackwell.
48. Hosenpud JD, McAnulty JH, Niles NR. Lack of objective improvement in ventricular systolic function in patients with myocarditis treated with azathioprine and prednisone. Journal of the American College of Cardiology 1985;6(4):797-801.
49. International Conference on Harmonisation Expert Working Group. Code of Federal Regulations & International Conference on Harmonisation Guidelines. Philadelphia: Barnett International/PAREXEL, 1997.
50. Kalil AC, Florescu DF. Is cytomegalovirus reactivation increasing the mortality of patients with severe sepsis?. Critical Care 2011;15(2):138.
51. Kandolf R. Diagnosis of myocarditis. Deutsche Medizinische Wochenschrift 2011;136(16):829-35.
52. Kearney MT, Cotton JM, Richardson PJ, Shah AM. Viral myocarditis and dilated cardiomyopathy: mechanisms, manifestations, and management. Postgraduate Medical Journal 2001;77(903):4-10.
53. Kraaij MD, Van der Kooij SW, Reinders ME, Koekkoek K, Rabelink TJ, Van Kooten C, et al.Dexamethasone increases ROS production and T cell suppressive capacity by anti-inflammatory macrophages. Molecular Immunology 2011;49(3):549-57.
54. Liu P, Martimo T, Opavsky MA, Penninger J. Viral myocarditis: balance between viral infection and immune response. Canadian Journal of Cardiology 1996;12(10):935-43.
55. Liu ZL, Liu ZJ, Liu JP, Kwong JSW. Herbal medicines for viral myocarditis. Cochrane Database of Systematic Reviews 2013, Issue 8. [DOI: 10.1002/14651858.CD003711.pub5]
56. Ma WZ, Yu JD, Liu ZQ, Wu N, Li LG, Chen HZ, et al. Committee of Myocarditis and Cardiomyopathy: Dealing meeting of Chinese Journal of Cardiovascular Disease. Viewpoints of diagnostic criteria of adult acute viral myocarditis and introduction to the definition and classification of cardiomyopathy of WHO/IHA workshop. Chinese Journal of Cardiovascular Disease 1999;27(6):405-7.
57. Magula NP, Mayosi BM. Cardiac involvement in HIV-infected people living in Africa: a review. Cardiovascular Journal of South Africa 2003;14(5):231-7. [PUBMED: 14610610]
58. Mahrholdt H, Goedecke C, Wagner A, Meinhardt G, Athanasiadis A, Vogelsberg H, et al.Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology. Circulation 2004;109(10):1250-8.
59. Mason JW. Myocarditis and dilated cardiomyopathy: An inflammatory link. Cardiovascular Research 2003;60(1):5-10.
60. McKenna WJ. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies. Circulation 1996;93(5):841-2.
61. McNamara DM. Diagnosis and medical treatment of inflammatory cardiomyopathy. In: Eric J. Topol editor(s). Textbook of Cardiovascular Medicine. 2nd Edition. Shangdong, China: Lippincott Williams & Wilkins; Shangdong Science & Technology Press, 2002:1899-1913. [: 7-5331-3409-5]
62. Metzger TC, Anderson MS. Myocarditis: a defect in central immune tolerance?. Journal of Clinical Investigation 2011;121(4):1251-3.
63. Opitz E, Koch A, Klingel K, Schmidt F, Prokop S, Rahnefeld A, et al.Impairment of immunoproteasome function by β5i/LMP7 subunit deficiency results in severe enterovirus myocarditis. PLoS Pathogens 2011;7(9):e1002233.
64. Orinius E. The late cardiac prognosis after Coxsackie-B infection. Acta Medica Scandinavica 1968;183:235-7.
65. Pietra BA, Kantor PF, Bartlett HL, Chin C, Canter CE, Larsen RL, et al.Early predictors of survival to and after heart transplantation in children with dilated cardiomyopathy. Circulation 2012;126(9):1079-86.
66. Figueira Salluh JI, Bozza FA, Japiassu AM, Castro Faria Neto HC, Bozza PT, Póvoa P. Corticosteroids in sepsis: pathophysiological rationale and selection of patients. Endocrine, Metabolic & Immune Disorders Drug Targets 2010;10(3):266-73.
67. Salvi A, Di LA, Dreas L, Silvestri F, Camerini F. Immunosuppressive treatment in myocarditis. International Journal of Cardiology 1989;22(3):329-38.
68. Schultz JC, Hilliard AA, Cooper LT, Rihal CS. Diagnosis and treatment of viral myocarditis. Mayo Clinic Proceedings 2009;84(11):1001-9.
69. Shauer A, Gotsman I, Keren A, Zwas DR, Hellman Y, Durst R, et al.Acute viral myocarditis: current concepts in diagnosis and treatment. Israel Medical Association Journal 2013;15(3):180-5.
70. Simon F, Paule P, Oliver M. Case Report: chikungunya virus-induced myopericarditis: toward an increase of dilated cardiomyopathy in countries with epidemics?. American Journal of Tropical Medicine and Hygiene 2008;78(2):212-3.
71. Sprung CL, Goodman S, Weiss YG. Steroid therapy of septic shock. Critical Care Nursing Clinics of North America 2011;23(1):171-80.
72. Tong P, Wu C, Jin H, Mao Q, Yu N, Holz JD, et al.Gene expression profile of steroid-induced necrosis of femoral head of rats. Calcified Tissue International 2011;89(4):271-84.
73. Uemura A, Morimoto S, Hiramitsu S, Hishida H. Endomyocardial biopsy findings in 50 patients with idiopathic atrioventricular block: presence of myocarditis. Japanese Heart Journal 2001;42(6):691-700.
74. Ukimura A, Ooi Y, Kanzaki Y, Inomata T, Izumi T. A national survey on myocarditis associated with influenza H1N1pdm2009 in the pandemic and post-pandemic season in Japan. Journal of Infection and Chemotherapy 2012; Vol. 19, issue 3:426-31.
75. Vester EG, Klein RM, Kuhl U, Schultheiss HP, Perings C, Hennersdorf M. Immunosuppressive therapy for effective suppression of life threatening ventricular tachyarrhythmias in chronic myocarditis. Zeitschrift fur Kardiologie 1997;86(4):298-308.
76. Yang F, Wu WF, Yan YL, Pang Y, Kong Q, Huang YL. Expression of IL-23/Th17 pathway in a murine model of Coxsackie virus B3-induced viral myocarditis. Virology Journal 2011;8:301.
77. Zahariadis G, Jerome KR, Corey L. Herpes simplex virus-associated sepsis in a previously infected immunocompetent adult. Annals of Internal Medicine 2003;139(2):153-4.
78. Zimmermann O, Kochs M, Zwaka TP, Kaya Z, Lepper PM, Bienek-Ziolkowski M, et al.Myocardial biopsy based classification and treatment in patients with dilated cardiomyopathy. International Journal of Cardiology 2005;104(1):92-100.
79. Chen HS, Yang M, Liu J. Corticosteroids for viral myocarditis. Cochrane Database of Systematic Reviews 2006, Issue 4. [DOI: 10.1002/14651858.CD004471.pub2]